David Steinberg
Stock Analyst at Jefferies
(2.77)
# 1,816
Out of 4,757 analysts
36
Total ratings
57.14%
Success rate
17.86%
Average return
Main Sectors:
Top Industries:
Stocks Rated by David Steinberg
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BHC Bausch Health Companies | Downgrades: Hold | $12 → $8 | $7.15 | +11.89% | 7 | Feb 6, 2025 | |
| PRGO Perrigo Company | Upgrades: Buy | $45 → $63 | $29.47 | +113.78% | 8 | Sep 30, 2021 | |
| SUPN Supernus Pharmaceuticals | Upgrades: Buy | $25 → $40 | $31.99 | +25.04% | 11 | Apr 13, 2021 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $151 → $188 | $140.23 | +34.07% | 5 | Oct 9, 2020 | |
| OCUL Ocular Therapeutix | Initiates: Buy | $8 | $7.15 | +11.89% | 1 | Mar 17, 2020 | |
| SCPH scPharmaceuticals | Maintains: Buy | $26 → $12 | $3.18 | +277.36% | 2 | Jun 14, 2018 | |
| OPTN OptiNose | Initiates: Buy | $405 | $5.44 | +7,344.85% | 1 | Nov 7, 2017 | |
| SVRA Savara | Initiates: Buy | $20 | $2.60 | +669.23% | 1 | Sep 22, 2017 |
Bausch Health Companies
Feb 6, 2025
Downgrades: Hold
Price Target: $12 → $8
Current: $7.15
Upside: +11.89%
Perrigo Company
Sep 30, 2021
Upgrades: Buy
Price Target: $45 → $63
Current: $29.47
Upside: +113.78%
Supernus Pharmaceuticals
Apr 13, 2021
Upgrades: Buy
Price Target: $25 → $40
Current: $31.99
Upside: +25.04%
Jazz Pharmaceuticals
Oct 9, 2020
Maintains: Buy
Price Target: $151 → $188
Current: $140.23
Upside: +34.07%
Ocular Therapeutix
Mar 17, 2020
Initiates: Buy
Price Target: $8
Current: $7.15
Upside: +11.89%
scPharmaceuticals
Jun 14, 2018
Maintains: Buy
Price Target: $26 → $12
Current: $3.18
Upside: +277.36%
OptiNose
Nov 7, 2017
Initiates: Buy
Price Target: $405
Current: $5.44
Upside: +7,344.85%
Savara
Sep 22, 2017
Initiates: Buy
Price Target: $20
Current: $2.60
Upside: +669.23%